The investigators propose a prospective, longitudinal study to examine decision-making about pre-surgery BRCA1/2 testing and the medical, psychosocial, and economic outcomes of testing among newly-diagnosed breast cancer patients who are at high risk for having a BRCA1/2 mutation. The theoretical framework for this investigation is derived from Expected Utility Theory.
The Specific aims are (1) to establish rates of uptake of the BRCA1/2 testing prior to surgical treatment for breast cancer and to identify the determinants of the decision to be tested; (2) to evaluate the impact of BRCA1/2 testing on patients' surgical treatment choices; (3) to evaluate the impact of pre-surgery BRTCA1/2 testing on psychological well-being; and (4) to develop a model to estimate the costs of BRCA1/2 testing for newly-diagnosed breast cancer patients per quality-adjusted life years saved. The subjects in this prospective longitudinal study are 400 newly diagnosed breast cancer patients who have an equal to or greater than 25 percent prior probability of having a BRCA1/2 mutation. A baseline assessment will be conducted prior to the offer of testing to collect data on background/controlling variables (sociodemographics, medical, physician and family factors), predictor/moderator variables (preferences for health outcomes, coping style, anxiety, social support), and baseline levels of outcome variables (psychosocial well being, prevention and surveillance practices). Following pre-test education and informed consent, patients will have an opportunity to have BRCA1/2 testing and receive their result during an individual session with a genetic counselor. Follow-up interviews will be conducted at 1-, 6-, 12-, and 18-months post-surgery to collect outcome data. The primary group comparisons in multiple regression models will be between BRCA1/2 carriers, non carriers, and pre-surgery test decliners. The proposed cost-effectiveness analysis will incorporate prospective data on patient preferences and outcomes together with secondary data from the literature, into a decision-analytic model.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074861-03
Application #
2896038
Study Section
Behavioral Medicine Study Section (BEM)
Program Officer
O'Mara, Ann M
Project Start
1997-08-01
Project End
2002-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Schwartz, Marc D; Peshkin, Beth N; Isaacs, Claudine et al. (2018) Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients. Breast Cancer Res Treat 170:517-524
King, Lesley; O'Neill, Suzanne C; Spellman, Elizabeth et al. (2013) Intentions for bilateral mastectomy among newly diagnosed breast cancer patients. J Surg Oncol 107:772-6
Graves, Kristi D; Peshkin, Beth N; Halbert, Chanita H et al. (2007) Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 104:321-9
Tercyak, Kenneth P; Peshkin, Beth N; Brogan, Barbara M et al. (2007) Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 25:285-91
Schwartz, Marc D; Lerman, Caryn; Brogan, Barbara et al. (2005) Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 14:1003-7
Schwartz, Marc D; Lerman, Caryn; Brogan, Barbara et al. (2004) Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 22:1823-9
Cullen, Jennifer; Schwartz, Marc D; Lawrence, William F et al. (2004) Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol 22:943-52
Lerman, Caryn; Croyle, Robert T; Tercyak, Kenneth P et al. (2002) Genetic testing: psychological aspects and implications. J Consult Clin Psychol 70:784-97
Schwartz, Marc D; Peshkin, Beth N; Hughes, Chanita et al. (2002) Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 20:514-20
Hughes, Chanita; Lerman, Caryn; Schwartz, Marc et al. (2002) All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 107:143-50

Showing the most recent 10 out of 12 publications